174 related articles for article (PubMed ID: 32316183)
1. Development and Study of Semi-Solid Preparations Containing the Model Substance Corticotropin (ACTH): Convenience Application in Neurodegenerative Diseases.
Siemiradzka W; Dolińska B; Ryszka F
Molecules; 2020 Apr; 25(8):. PubMed ID: 32316183
[TBL] [Abstract][Full Text] [Related]
2. Influence of Concentration on Release and Permeation Process of Model Peptide Substance-Corticotropin-From Semisolid Formulations.
Siemiradzka W; Dolińska B; Ryszka F
Molecules; 2020 Jun; 25(12):. PubMed ID: 32549368
[TBL] [Abstract][Full Text] [Related]
3. [Effect of Mixing Time and Storage Condition on Characterization of Heparinoid Admixtures with Corticosteroids].
Sugiyama I; Takahashi N; Sadzuka Y
Yakugaku Zasshi; 2016; 136(10):1391-1400. PubMed ID: 27725389
[TBL] [Abstract][Full Text] [Related]
4. Physicochemical attributes and dissolution testing of ophthalmic ointments.
Bao Q; Jog R; Shen J; Newman B; Wang Y; Choi S; Burgess DJ
Int J Pharm; 2017 May; 523(1):310-319. PubMed ID: 28344172
[TBL] [Abstract][Full Text] [Related]
5. In vitro and ex vivo correlation of drug release from ophthalmic ointments.
Bao Q; Newman B; Wang Y; Choi S; Burgess DJ
J Control Release; 2018 Apr; 276():93-101. PubMed ID: 29518465
[TBL] [Abstract][Full Text] [Related]
6. Formulation characteristics and in vitro release testing of cyclosporine ophthalmic ointments.
Dong Y; Qu H; Pavurala N; Wang J; Sekar V; Martinez MN; Fahmy R; Ashraf M; Cruz CN; Xu X
Int J Pharm; 2018 Jun; 544(1):254-264. PubMed ID: 29684560
[TBL] [Abstract][Full Text] [Related]
7. In vitro release testing method development for ophthalmic ointments.
Bao Q; Shen J; Jog R; Zhang C; Newman B; Wang Y; Choi S; Burgess DJ
Int J Pharm; 2017 Jun; 526(1-2):145-156. PubMed ID: 28461266
[TBL] [Abstract][Full Text] [Related]
8. Development of an Ointment Formulation Using Hot-Melt Extrusion Technology.
Bhagurkar AM; Angamuthu M; Patil H; Tiwari RV; Maurya A; Hashemnejad SM; Kundu S; Murthy SN; Repka MA
AAPS PharmSciTech; 2016 Feb; 17(1):158-66. PubMed ID: 26628438
[TBL] [Abstract][Full Text] [Related]
9. Perspectives on Physicochemical and In Vitro Profiling of Ophthalmic Ointments.
Bao Q; Burgess DJ
Pharm Res; 2018 Oct; 35(12):234. PubMed ID: 30324424
[TBL] [Abstract][Full Text] [Related]
10. Influence of plasma on the physical properties of ointments with quercetin.
Szulc-Musioł B; Dolińska B; Kołodziejska J; Ryszka F
Acta Pharm; 2017 Dec; 67(4):569-578. PubMed ID: 29337672
[TBL] [Abstract][Full Text] [Related]
11. Formulation and process factors influencing product quality and in vitro performance of ophthalmic ointments.
Xu X; Al-Ghabeish M; Rahman Z; Krishnaiah YS; Yerlikaya F; Yang Y; Manda P; Hunt RL; Khan MA
Int J Pharm; 2015 Sep; 493(1-2):412-25. PubMed ID: 26231106
[TBL] [Abstract][Full Text] [Related]
12. Study of tolnaftate release from fatty acids containing ointment and penetration into human skin ex vivo.
Kezutyte T; Drevinskas T; Maruska A; Rimdeika R; Briedis V
Acta Pol Pharm; 2011; 68(6):965-73. PubMed ID: 22125963
[TBL] [Abstract][Full Text] [Related]
13. In vitro release, rheological, and stability studies of mefenamic acid coprecipitates in topical formulations.
Ahmed TA; Ibrahim HM; Ibrahim F; Samy AM; Fetoh E; Nutan MT
Pharm Dev Technol; 2011 Oct; 16(5):497-510. PubMed ID: 20550465
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous absorption of ibuprofen from different formulations. Comparative study with gel, hydrophilic ointment and emulsion cream.
Seth PL
Arzneimittelforschung; 1993 Aug; 43(8):919-21. PubMed ID: 8216453
[TBL] [Abstract][Full Text] [Related]
15. Effects of mixing procedure itself on the structure, viscosity, and spreadability of white petrolatum and salicylic acid ointment and the skin permeation of salicylic acid.
Kitagawa S; Fujiwara M; Okinaka Y; Yutani R; Teraoka R
Chem Pharm Bull (Tokyo); 2015; 63(1):43-8. PubMed ID: 25400272
[TBL] [Abstract][Full Text] [Related]
16. Influence of drug loading and type of ointment base on the in vitro performance of acyclovir ophthalmic ointment.
Al-Ghabeish M; Xu X; Krishnaiah YS; Rahman Z; Yang Y; Khan MA
Int J Pharm; 2015 Nov; 495(2):783-91. PubMed ID: 26343911
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of creams and ointments as suitable formulations for peldesine.
Viegas TX; Van Winkle LL; Lehman PA; Franz SF; Franz TJ
Int J Pharm; 2001 May; 219(1-2):73-80. PubMed ID: 11337167
[TBL] [Abstract][Full Text] [Related]
18. Formulation of colchicine ointment for the treatment of acute gout.
Maduri S; Atla VR
Singapore Med J; 2012 Nov; 53(11):750-4. PubMed ID: 23192503
[TBL] [Abstract][Full Text] [Related]
19. [Formulation of the composition of a polymyxin ointment using a mathematical experimental design].
Oganesian NR; Kagan EZ; Griadunova GP; Fishman VM
Antibiot Med Biotekhnol; 1986 Jun; 31(6):437-9. PubMed ID: 3017200
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory effect of diclofenac-sodium ointment (cream) in topical application.
Kyuki K; Shibuya T; Tsurumi K; Fujimura H
Jpn J Pharmacol; 1983 Feb; 33(1):121-32. PubMed ID: 6876511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
